News
Novo Nordisk (NYSE: NVO) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight ...
Results showed that replacing a half-hour of sedentary time with a half-hour of moderate-to-vigorous physical activity every ...
That’s a bit harsh given Denmark’s strong growth compared with neighboring countries over the past few years has been largely ...
Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...
As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have they changed positions in the annual IDEA Pharma Innovation Index, which ...
I add two companies to our Dividend Income Accelerator Portfolio each month. Find out why I have added Novo Nordisk (NVO) and ...
Explore more
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
Denmark has revised its 2026 economic growth forecast to 1.4% due to uncertainty from U.S. trade tensions. The pharmaceutical ...
Long Island patients lost vision after taking weight loss drugs Ozempic and Wegovy, lawsuits contend
The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...
U.S. companies are increasingly issuing bonds in the euro credit market as it is cheaper than issuing in the dollar credit market, CreditSights said. "A mix of European Central Bank policy loosening ...
A miracle drug just wiped out WeightWatchers International’s (WW) 60-year empire. Here’s how Ozempic disrupted the weight ...
Qure.AI, an India-based startup providing artificial intelligence tools to healthcare firms, is aiming to turn profitable in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results